Literature DB >> 33055282

Regulatory T Cells Maintain Selective Access to IL-2 and Immune Homeostasis despite Substantially Reduced CD25 Function.

Erika T Hayes1,2, Cassidy E Hagan1,2, Liliane Khoryati1, Marc A Gavin1, Daniel J Campbell3,2.   

Abstract

IL-2 is a critical regulator of immune homeostasis through its impact on both regulatory T (Treg) and effector T cells. However, the precise role of IL-2 in the maintenance and function of Treg cells in the adult peripheral immune system remains unclear. In this study, we report that neutralization of IL-2 in mice abrogated all IL-2R signaling in Treg cells, but was well tolerated and only gradually impacted Treg cell function and immune homeostasis. By contrast, despite substantially reduced IL-2 sensitivity, Treg cells maintained selective IL-2 signaling and prevented immune dysregulation following treatment with the inhibitory anti-CD25 Ab PC61. Reduction of Treg cells with a depleting version of the same CD25 Ab permitted CD8+ effector T cell proliferation before progressing to more widespread immune dysregulation. Thus, despite severely curtailed CD25 expression and function, Treg cells retain selective access to IL-2 that supports their anti-inflammatory functions in vivo. Ab-mediated targeting of CD25 is being actively pursued for treatment of autoimmune disease and prevention of allograft rejection, and our findings help inform therapeutic manipulation and design for optimal patient outcomes.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33055282      PMCID: PMC7657993          DOI: 10.4049/jimmunol.1901520

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

1.  Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin 2 receptor: relationship to the interleukin 2-binding site.

Authors:  J L Moreau; M Nabholz; T Diamantstein; T Malek; E Shevach; J Thèze
Journal:  Eur J Immunol       Date:  1987-07       Impact factor: 5.532

2.  Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice.

Authors:  Kevin N Couper; Daniel G Blount; J Brian de Souza; Isabelle Suffia; Yasmine Belkaid; Eleanor M Riley
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

3.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.

Authors:  Jeong M Kim; Jeffrey P Rasmussen; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2006-11-30       Impact factor: 25.606

4.  In vivo maintenance of human regulatory T cells during CD25 blockade.

Authors:  David J Huss; Devangi S Mehta; Akanksha Sharma; Xiaojun You; Katherine A Riester; James P Sheridan; Lakshmi S Amaravadi; Jacob S Elkins; Jason D Fontenot
Journal:  J Immunol       Date:  2015-01-01       Impact factor: 5.422

5.  A 33D1+ Dendritic Cell/Autoreactive CD4+ T Cell Circuit Maintains IL-2-Dependent Regulatory T Cells in the Spleen.

Authors:  J Michael Stolley; Daniel J Campbell
Journal:  J Immunol       Date:  2016-08-26       Impact factor: 5.422

6.  Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells.

Authors:  Adam P Kohm; Jeffrey S McMahon; Joseph R Podojil; Wendy Smith Begolka; Mathew DeGutes; Deborah J Kasprowicz; Steven F Ziegler; Stephen D Miller
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

7.  Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction.

Authors:  Qizhi Tang; Jason Y Adams; Cristina Penaranda; Kristin Melli; Eliane Piaggio; Evridiki Sgouroudis; Ciriaco A Piccirillo; Benoit L Salomon; Jeffrey A Bluestone
Journal:  Immunity       Date:  2008-05-08       Impact factor: 31.745

8.  Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation.

Authors:  G Vlad; E K Ho; E R Vasilescu; J Fan; Z Liu; J W Cai; Z Jin; E Burke; M Deng; M Cadeiras; R Cortesini; S Itescu; C Marboe; D Mancini; N Suciu-Foca
Journal:  Transpl Immunol       Date:  2007-04-02       Impact factor: 1.708

9.  IL-2Rβ abundance differentially tunes IL-2 signaling dynamics in CD4+ and CD8+ T cells.

Authors:  Geoffrey A Smith; Jack Taunton; Arthur Weiss
Journal:  Sci Signal       Date:  2017-12-19       Impact factor: 8.192

Review 10.  Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsing Multiple Sclerosis.

Authors:  Stanley L Cohan; Elisabeth B Lucassen; Meghan C Romba; Stefanie N Linch
Journal:  Biomedicines       Date:  2019-03-11
View more
  2 in total

1.  Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation.

Authors:  Abir K Panda; Yong-Hee Kim; Ethan M Shevach
Journal:  J Immunol       Date:  2022-01-17       Impact factor: 5.426

2.  Impaired activation of STAT5 upon IL-2 stimulation in Tregs and elevated sIL-2R in Sjögren's syndrome.

Authors:  Magdalena Keindl; Richard Davies; Brith Bergum; Johan G Brun; Daniel Hammenfors; Roland Jonsson; Valeriya Lyssenko; Silke Appel
Journal:  Arthritis Res Ther       Date:  2022-05-07       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.